5 Results for "

NF2-deficient

" in MedChemExpress (MCE) Product Catalog:
Products (5)

5 Results for "NF2-deficient" in MCE Product Catalog:

10
10 Cited Publications
Cat. No.: HY-134957
CAS No.: 2417718-63-7
Purity:  99.89%
Target:  

YAP

Research Areas:  

Cancer

VT-107, as an analogous to VT104, is an orally active and potent pan-TEAD auto-palmitoylation inhibitor. VT-107 can be used for the research of cancer .
loading...
    loading...
Cat. No.: HY-400902
CAS No.: 2506273-81-8
Target:  

YAP VEGFR Hippo (MST)

Research Areas:  

Cancer

VT3989 is an orally active pan-TEAD autopalmitoylation inhibitor that modulates the Hippo signaling pathway. VT3989 directly binds to TEAD transcription factors to block their palmitoylation modification, thereby disrupting the formation of YAP/TAZ-TEAD complexes and inhibiting downstream oncogenic transcriptional activity. VT3989 effectively inhibits the growth of NF2-deficient schwannoma and meningioma cells and reverses the Schwann cell phenotype. In addition, VT3989 exerts a synergistic effect when combined with Osimtinib (HY-15772) in EGFR-mutant non-small cell lung cancer models, significantly delaying tumor recurrence and prolonging survival. VT3989 can be used for the research of epithelioid hemangioendothelioma, malignant pleural mesothelioma, type 2 neurofibromatosis and related advanced solid tumors [2] .
loading...
    loading...
Cat. No.: HY-158342
CAS No.: 3061498-57-2
Purity:  99.82%
Target:  

PROTACs YAP

Research Areas:  

Cancer

PROTAC TEAD degrader-1 is a TEAD2 degrader and antiproliferative agent with selective activity toward TEAD2 relative to other TEAD family members. PROTAC TEAD degrader-1 relies on CRBN and the proteasome system for TEAD2 degradation; disruption of CRBN binding attenuates this activity. PROTAC TEAD degrader-1 decreases expression of YAP target genes CYR61 and CTGF. PROTAC TEAD degrader-1 can be used for the research of NF2-deficient cancer .
loading...
    loading...
Cat. No.: HY-163644
CAS No.: 2417718-38-6
Target:  

YAP

Research Areas:  

Cancer

VT-105 is a TEAD inhibitor and VT104 (HY-134956) analog. VT-105 binds to the central hydrophobic pocket of the TEAD3 protein. VT-105 can be used in the research of NF2-deficient malignant mesothelioma [2].
loading...
    loading...
Cat. No.: HY-183728
Target:  

YAP

Research Areas:  

Cancer

LC-TEAD01 is a potent covalent transcription enhancer-associated domain (TEAD) inhibitor with an IC50 of 116 nM and a Ki of 0.132 μM. LC-TEAD01 disrupts the TEAD-YAP interaction and inhibits TEAD-dependent transcriptional activity. LC-TEAD01 suppresses the proliferation of NF2-deficient cancer cells. LC-TEAD01 inhibits tumor growth in NF2-deficient xenograft models. LC-TEAD01 can be used in studies related to NF2-deficient malignant pleural mesothelioma .
loading...
    loading...